Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
- PMID: 23642316
- PMCID: PMC3748225
- DOI: 10.1016/j.drugalcdep.2013.02.036
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
Abstract
Background: Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
Methods: Data from a nationally representative sample of US adults were used to compare concordance of past-year DSM-IV opioid, cannabis, cocaine and alcohol dependence with past-year DSM-5 disorders at thresholds of 3+, 4+, 5+ and 6+ positive DSM-5 criteria among past-year users of opioids (n=264), cannabis (n=1622), cocaine (n=271) and alcohol (n=23,013). Substance-specific 2 × 2 tables yielded overall concordance (kappa), sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV).
Results: For DSM-IV alcohol, cocaine and opioid dependence, optimal concordance occurred when 4+ DSM-5 criteria were endorsed, corresponding to the threshold for moderate DSM-5 alcohol, cocaine and opioid use disorders. Maximal concordance of DSM-IV cannabis dependence and DSM-5 cannabis use disorder occurred when 6+ criteria were endorsed, corresponding to the threshold for severe DSM-5 cannabis use disorder. At these optimal thresholds, sensitivity, specificity, PPV and NPV generally exceeded 85% (>75% for cannabis).
Conclusions: Overall, excellent correspondence of DSM-IV dependence with DSM-5 substance use disorders was documented in this general population sample of alcohol, cannabis, cocaine and opioid users. Applicability of treatments tested for DSM-IV dependence is supported by these results for those with a DSM-5 alcohol, cocaine or opioid use disorder of at least moderate severity or severe cannabis use disorder. Further research is needed to provide evidence for applicability of treatments for persons with milder substance use disorders.
Keywords: Concordance; DSM-5; DSM-IV; Diagnosis; Kappa; Substance use disorder.
Published by Elsevier Ireland Ltd.
Conflict of interest statement
All authors are Federal government employees, and none of the authors has any financial conflict of interest to report.
Similar articles
-
Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.Drug Alcohol Depend. 2013 Jan 1;127(1-3):215-9. doi: 10.1016/j.drugalcdep.2012.07.009. Epub 2012 Aug 9. Drug Alcohol Depend. 2013. PMID: 22884164 Free PMC article.
-
Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.J Clin Psychiatry. 2016 Apr;77(4):e444-50. doi: 10.4088/JCP.14m09469. J Clin Psychiatry. 2016. PMID: 27137428
-
Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample.J Stud Alcohol Drugs. 2012 Sep;73(5):820-8. doi: 10.15288/jsad.2012.73.820. J Stud Alcohol Drugs. 2012. PMID: 22846246 Free PMC article.
-
The importance of considering polysubstance use: lessons from cocaine research.Drug Alcohol Depend. 2018 Nov 1;192:16-28. doi: 10.1016/j.drugalcdep.2018.07.025. Epub 2018 Sep 1. Drug Alcohol Depend. 2018. PMID: 30195242 Free PMC article. Review.
-
Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey.Lancet Psychiatry. 2016 Jul;3(7):673-84. doi: 10.1016/S2215-0366(16)00088-2. Lancet Psychiatry. 2016. PMID: 27371989 Review.
Cited by
-
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids.Drug Alcohol Depend Rep. 2024 Feb 14;10:100220. doi: 10.1016/j.dadr.2024.100220. eCollection 2024 Mar. Drug Alcohol Depend Rep. 2024. PMID: 38414666 Free PMC article.
-
An exploratory study of cannabis use pattern and treatment seeking in patients attending an addiction treatment facility.Indian J Psychiatry. 2020 Mar-Apr;62(2):145-151. doi: 10.4103/psychiatry.IndianJPsychiatry_132_19. Epub 2020 Mar 17. Indian J Psychiatry. 2020. PMID: 32382173 Free PMC article.
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
-
Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial.Am J Psychiatry. 2022 Dec 1;179(12):915-926. doi: 10.1176/appi.ajp.20220335. Epub 2022 Oct 26. Am J Psychiatry. 2022. PMID: 36285404 Free PMC article. Clinical Trial.
-
Treatment Journey and Healthcare Resource Use Among Patients With Alcohol Use Disorder Who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs Data.Subst Use. 2024 Sep 26;18:29768357241280713. doi: 10.1177/29768357241280713. eCollection 2024 Jan-Dec. Subst Use. 2024. PMID: 39346703 Free PMC article.
References
-
- American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association; 1994.
-
- Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry. 2007;64:566–576. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous